Kainomyx — Antimalarial Drug (2025)
Verified$900K
Funder
Recipient
Kainomyx
Date
Dec 2024
Data source
Source
Notes
[Scientific Research] Open Philanthropy recommended an investment of $899,999 in Kainomyx to discover and develop novel therapeutics with unique mechanisms of action to treat malaria and other parasitic diseases. If effective, the new drugs would act by inhibiting cytoskeletal proteins in malarial and other parasites. This follows our September 2021 investment and falls within our work on scientific research, specifically within our interest in advancing human health and wellbeing. The grant amount was updated in September 2025.
Other Grants by Coefficient Giving
2625| Grant | Recipient | Amount | Date |
|---|---|---|---|
| Janaagraha — Air Quality Grants Assessment | $195K | Dec 2024 | |
| Futurewise — Housing Advocacy in Washington | $450K | Apr 2023 | |
| Exscientia — Agonists for Interferon Lambda | $2.3M | Sep 2023 | |
| Kurzgesagt — Short-form Video Content | $3M | Mar 2022 | |
| Kurzgesagt — Video Production (2023) | $1.7M | May 2023 | |
| Kurzgesagt — Video Creation and Translation | $2.6M | Dec 2021 | |
| Lightcone Infrastructure – General Support | Lighthaven (Event Venue) | $4.5M | Sep 2022 |
| Lightcone Infrastructure — General Support (2023) | Lighthaven (Event Venue) | $3M | Oct 2023 |
| Conjecture — Cybersecurity Bootcamp | Conjecture | $223K | Jun 2025 |
| Conjecture — AI Safety Technical Program | Conjecture | $224K | May 2023 |
Showing 10 of 2625 grants